Gemvax AS
Records under this name other than patents Gemvax AS holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,030,211 | Antigenic peptides derived from telomerase Term ended Term ended Apr 18, 2023 · From the USPTO record | Term ended | Term ended Apr 18, 2023 | From the USPTO record |
| US 7,078,416 | Polypeptides Term ended Term ended Apr 15, 2022 · From the USPTO record | Term ended | Term ended Apr 15, 2022 | From the USPTO record |
| US 6,759,046 | Peptides Term ended Term ended Jun 4, 2021 · From the USPTO record | Term ended | Term ended Jun 4, 2021 | From the USPTO record |
| US 7,863,244 | Peptides Term ended Term ended Dec 1, 2020 · From the USPTO record | Term ended | Term ended Dec 1, 2020 | From the USPTO record |
| US 8,193,326 | Nucleic acids encoding novel TERT polypeptides Lapsed on the fee record Ended Jun 5, 2020 · From the USPTO record | Lapsed on the fee record | Ended Jun 5, 2020 | From the USPTO record |
| US 7,375,117 | Polypeptides Lapsed on the fee record Ended May 20, 2020 · From the USPTO record | Lapsed on the fee record | Ended May 20, 2020 | From the USPTO record |
| US 7,192,927 | Peptides Term ended Term ended Apr 26, 2020 · From the USPTO record | Term ended | Term ended Apr 26, 2020 | From the USPTO record |
| US 8,614,177 | Peptides Term ended Term ended Jun 5, 2019 · From the USPTO record | Term ended | Term ended Jun 5, 2019 | From the USPTO record |
| US 7,794,723 | Antigenic peptides derived from telomerase Term ended Term ended Aug 2, 2010 · From the USPTO record | Term ended | Term ended Aug 2, 2010 | From the USPTO record |
| US 6,861,057 | Immunogenic β-amyloid peptide Lapsed on the fee record Ended Mar 1, 2009 · From the USPTO record | Lapsed on the fee record | Ended Mar 1, 2009 | From the USPTO record |